C Ward
John Wiley & Sons
e druk, 2009
9780470695173
A Practical Guide to Heart Failure in Older People
Specificaties
Gebonden, 294 blz.
|
Engels
John Wiley & Sons |
2009
ISBN13: 9780470695173
Rubricering
Verwachte levertijd ongeveer 16 werkdagen
Samenvatting
Heart failure is effectively a disease of older people. Eighty percent of patients are over 65 years old, and the majority of these are over 75. This figure is likely to increase significantly in the next two decades. The prognosis is worse than that of most cancers and heart failure is the commonest reason for hospital admission in the over 65s.
The problems associated with treating heart failure in older patients are more diverse and complex than in those who are younger. The diagnosis in older patients is easily overlooked and as they were excluded from most heart failure treatment trials there has been a reluctance to treat them optimally (fewer than 20% are prescribed conventional medicines). They have multiple co–morbidities which are poorly managed, they are repeatedly hospitalised, and suffer social isolation.
These important age–related treatment and management problems have been largely ignored and this book aims to redress the balance. It provides a concise, comprehensive account of the epidemiology, pathogenesis, diagnosis, treatment, management and end–of–life care of elderly patients with heart failure, based on published studies.
A Practical Guide to Heart Failure in Older People is essential reading for geriatricians, cardiologists, general hospital physicians, family practitioners and specialist nurses.
Specifically addresses the particular needs of the elderly, a largely ignored group who constitute the majority of patients with heart failure
Presents a concise yet comprehensive account of the evidence relating to the diagnosis, treatment and management of heart failure in this population
Improves awareness of the various roles within the management team
Specificaties
Inhoudsopgave
<p>Preface xi</p>
<p>List of Contributors xiii</p>
<p>1 Introduction 1<br />Christopher Ward</p>
<p>1.1 A Working Definition of Heart Failure 1</p>
<p>1.2 What do We Mean by Older People? 2</p>
<p>1.3 The Expectations of Older Patients 4</p>
<p>1.4 Age–Related Problems in Heart Failure Treatment and Management 4</p>
<p>1.5 The Level of Evidence for Treating Older Patients 6</p>
<p>References 7</p>
<p>2 Epidemiology 9<br />Christopher Ward</p>
<p>2.1 Epidemiology, Demography and Prognosis 9</p>
<p>2.2 Heart Failure with Preserved Left Ventricular Systolic Function (HF–PSF) 10</p>
<p>2.3 Prevalence, Incidence and Prognosis 11</p>
<p>2.4 Age and Prognosis 14</p>
<p>2.5 The Effects of Gender and Race on Prevalence and Prognosis 18</p>
<p>2.6 The Increasing Prevalence of Heart Failure and Longevity 19</p>
<p>2.7 The Implications of Epidemiological and Demographic Data 20</p>
<p>References 22</p>
<p>3 Heart Failure and the Aging Heart 27<br />Helen Oxenham</p>
<p>3.1 Introduction 27</p>
<p>3.2 Overt and Subclinical Cardiovascular Disease in Older People 28</p>
<p>3.3 Age–Related Changes to Cardiac Structure and Function 33</p>
<p>3.4 Other Relevant Age–Related Changes 35</p>
<p>3.5 Responses of the Aging Cardiovascular System to Exercise, Normal Daily Activities and to Other Physiological Stresses 36</p>
<p>3.6 The Pathogenesis of Heart Failure 38</p>
<p>3.7 The Impact of Age–Related Changes to the Cardiovascular System on the Responses to Myocardial Damage 40</p>
<p>3.8 The Prevention of Heart Failure in Older People 40</p>
<p>References 41</p>
<p>4 Aetiology 45<br />Christopher Ward</p>
<p>4.1 Classification of the Aetiologies of Heart Failure 45</p>
<p>4.2 The Importance of Identifying the Aetiology 47</p>
<p>4.3 Specific Aetiologies 48</p>
<p>4.4 Post–Myocardial Infarction (Post–MI) Heart Failure 49</p>
<p>4.5 Valvular Disease 51</p>
<p>4.6 The Cardiomyopathies 56</p>
<p>4.7 Atrial Fibrillation 57</p>
<p>References 58</p>
<p>5 Diagnosis 63<br />Christopher Ward</p>
<p>5.1 Diagnostic Guidelines 64</p>
<p>5.2 Symptoms and Signs: Sensitivity and Specificity 65</p>
<p>5.3 Objective Evidence of Left Ventricular Systolic Dysfunction 66</p>
<p>5.4 Diagnostic Difficulties in Older Patients 70</p>
<p>5.5 Diagnosis, Patient Management and Clinical Profile 73</p>
<p>References 76</p>
<p>6 Pharmacological Treatment 79<br />Miles D. Witham</p>
<p>6.1 Introduction 79</p>
<p>6.2 ACE Inhibitors 81</p>
<p>6.3 Beta–Blockers 83</p>
<p>6.4 Spironolactone 85</p>
<p>6.5 Diuretics 87</p>
<p>6.6 Digoxin 88</p>
<p>6.7 Hydralazine and Nitrates 89</p>
<p>6.8 Adding Angiotensin Receptor Blockers to ACE Inhibitors 90</p>
<p>6.9 Treating the Underlying Cardiovascular Disease 90</p>
<p>6.10 Medications to Avoid 90</p>
<p>6.11 Prescribing for Heart Failure with Preserved Systolic Function 92</p>
<p>6.12 Prescribing for Multiple Comorbidities 92</p>
<p>6.13 Prescribing at the End of Life 93</p>
<p>References 93</p>
<p>7 Non–Pharmacological Management 97<br />Sinéad P. McKee and Miles D. Witham</p>
<p>7.1 Exercise Training 97</p>
<p>7.2 Types of Exercise Programme 98</p>
<p>7.3 Smoking 100</p>
<p>7.4 Diet 101</p>
<p>7.5 Alcohol 103</p>
<p>7.6 Vaccinations 104</p>
<p>7.7 Psychological Interventions 104</p>
<p>References 104</p>
<p>8 Comorbidity 107<br />Andrew Elder</p>
<p>8.1 Introduction 107</p>
<p>8.2 The Prevalence of Comorbidities 109</p>
<p>8.3 The Implications of Comorbidity 109</p>
<p>8.4 Specific Comorbidities in Heart Failure 111</p>
<p>References 127</p>
<p>9 Treatment and Management in Primary Care 133<br />Alan Begg</p>
<p>9.1 Introduction 134</p>
<p>9.2 The Role of Primary Care and the Patient Population 134</p>
<p>9.3 Heart Failure Registers, Data Collection and Audit 135</p>
<p>9.4 Heart Failure in General Practice 140</p>
<p>9.5 Treatment and Management 146</p>
<p>9.6 Specific Problems in Treating Older Patients 150</p>
<p>References 152</p>
<p>10 The Role of the Specialist Nurse 157<br />Sinéad P. McKee</p>
<p>10.1 Introduction 157</p>
<p>10.2 The Role of the Specialist Nurse 158</p>
<p>10.3 Clinic–Based versus Home–Based Service 163</p>
<p>10.4 Multidisciplinary Team Liaison 165</p>
<p>10.5 Specific Issues Affecting Older Patients 166</p>
<p>10.6 End of Life Care 169</p>
<p>10.7 Specialist Nurses and Education 169</p>
<p>References 171</p>
<p>11 The Role of the Heart Failure Specialist 175<br />Maheshwar Pauriah, Aaron K.F. Wong and Chim C. Lang</p>
<p>11.1 Introduction 175</p>
<p>11.2 The Role of the Heart Failure Specialist 176</p>
<p>11.3 The Provision of a Diagnostic Service and Patient Assessment 177</p>
<p>11.4 Management of Patients with Acute or Worsening Heart Failure Symptoms 178</p>
<p>11.5 Optimization of Heart Failure Treatment 180</p>
<p>11.6 Treatment of Reversible Causes of Heart Failure 184</p>
<p>11.7 Treatment of Concomitant Diseases 187</p>
<p>11.8 Multidisciplinary Care 189</p>
<p>References 191</p>
<p>12 Hospitalization 197<br />Andrew Hannah</p>
<p>12.1 The Epidemiology of Hospitalization 197</p>
<p>12.2 The Aetiology of Heart Failure in Hospitalized Patients 198</p>
<p>12.3 Classification and Diagnosis of Acute Heart Failure (AHF) 199</p>
<p>12.4 Causes and Precipitants of Hospitalization 201</p>
<p>12.5 Treatment of Acute Heart Failure 205</p>
<p>12.6 Management of the Common Cardiac Causes of Hospitalization for Heart Failure 208</p>
<p>12.7 Outcomes in Patients Hospitalized for Heart Failure 209</p>
<p>12.8 Strategies to Reduce Admissions and Readmissions in Patients with Heart Failure 210</p>
<p>References 211</p>
<p>13 Models of Care and Disease Management Programmes 215<br />Martin Wilson and Stephen J. Leslie</p>
<p>13.1 Introduction 215</p>
<p>13.2 Disease Management Programmes 218</p>
<p>13.3 Disease Management Programmes: The Evidence 227</p>
<p>13.4 Guidelines and Critical Care Pathways 228</p>
<p>13.5 Remote and Rural Issues 231</p>
<p>13.6 Telecardiology in Heart Failure 232</p>
<p>13.7 Conclusions 235</p>
<p>References 235</p>
<p>14 Palliative and Supportive Care for Patients with Advanced and Terminal Heart Failure 241<br />Christopher Ward, Francis G. Dunn, Shona M.M. Jenkins and Martin Leiper</p>
<p>14.1 What is Palliative Care? 242</p>
<p>14.2 Age–Related Problems and the Provision of Palliative Care 243</p>
<p>14.3 Advanced and Terminal Heart Failure 244</p>
<p>14.4 Management of Specific Symptoms 248</p>
<p>14.5 Home and Hospital Care 253</p>
<p>14.6 Withdrawal of Conventional Drugs 254</p>
<p>14.7 The Palliative Care Needs of Heart Failure Patients 254</p>
<p>14.8 Palliative Care Strategies for Heart Failure 256</p>
<p>14.9 Timing the Introduction of Different Palliative Care Strategies 256</p>
<p>14.10 Cardiological Issues 259</p>
<p>14.11 The Management Implications of Advanced Heart Failure 260</p>
<p>14.12 Control of Symptoms Using Mostly Generic Treatments 261</p>
<p>14.13 Support in the Community: The Gold Standard Framework (GSF) and Advanced Care Planning (ACP) 262</p>
<p>14.14 Terminal Heart Failure: Identifying the Dying Patient and Providing End–of–Life Care 263</p>
<p>References 265</p>
<p>Index 271</p>
<p>List of Contributors xiii</p>
<p>1 Introduction 1<br />Christopher Ward</p>
<p>1.1 A Working Definition of Heart Failure 1</p>
<p>1.2 What do We Mean by Older People? 2</p>
<p>1.3 The Expectations of Older Patients 4</p>
<p>1.4 Age–Related Problems in Heart Failure Treatment and Management 4</p>
<p>1.5 The Level of Evidence for Treating Older Patients 6</p>
<p>References 7</p>
<p>2 Epidemiology 9<br />Christopher Ward</p>
<p>2.1 Epidemiology, Demography and Prognosis 9</p>
<p>2.2 Heart Failure with Preserved Left Ventricular Systolic Function (HF–PSF) 10</p>
<p>2.3 Prevalence, Incidence and Prognosis 11</p>
<p>2.4 Age and Prognosis 14</p>
<p>2.5 The Effects of Gender and Race on Prevalence and Prognosis 18</p>
<p>2.6 The Increasing Prevalence of Heart Failure and Longevity 19</p>
<p>2.7 The Implications of Epidemiological and Demographic Data 20</p>
<p>References 22</p>
<p>3 Heart Failure and the Aging Heart 27<br />Helen Oxenham</p>
<p>3.1 Introduction 27</p>
<p>3.2 Overt and Subclinical Cardiovascular Disease in Older People 28</p>
<p>3.3 Age–Related Changes to Cardiac Structure and Function 33</p>
<p>3.4 Other Relevant Age–Related Changes 35</p>
<p>3.5 Responses of the Aging Cardiovascular System to Exercise, Normal Daily Activities and to Other Physiological Stresses 36</p>
<p>3.6 The Pathogenesis of Heart Failure 38</p>
<p>3.7 The Impact of Age–Related Changes to the Cardiovascular System on the Responses to Myocardial Damage 40</p>
<p>3.8 The Prevention of Heart Failure in Older People 40</p>
<p>References 41</p>
<p>4 Aetiology 45<br />Christopher Ward</p>
<p>4.1 Classification of the Aetiologies of Heart Failure 45</p>
<p>4.2 The Importance of Identifying the Aetiology 47</p>
<p>4.3 Specific Aetiologies 48</p>
<p>4.4 Post–Myocardial Infarction (Post–MI) Heart Failure 49</p>
<p>4.5 Valvular Disease 51</p>
<p>4.6 The Cardiomyopathies 56</p>
<p>4.7 Atrial Fibrillation 57</p>
<p>References 58</p>
<p>5 Diagnosis 63<br />Christopher Ward</p>
<p>5.1 Diagnostic Guidelines 64</p>
<p>5.2 Symptoms and Signs: Sensitivity and Specificity 65</p>
<p>5.3 Objective Evidence of Left Ventricular Systolic Dysfunction 66</p>
<p>5.4 Diagnostic Difficulties in Older Patients 70</p>
<p>5.5 Diagnosis, Patient Management and Clinical Profile 73</p>
<p>References 76</p>
<p>6 Pharmacological Treatment 79<br />Miles D. Witham</p>
<p>6.1 Introduction 79</p>
<p>6.2 ACE Inhibitors 81</p>
<p>6.3 Beta–Blockers 83</p>
<p>6.4 Spironolactone 85</p>
<p>6.5 Diuretics 87</p>
<p>6.6 Digoxin 88</p>
<p>6.7 Hydralazine and Nitrates 89</p>
<p>6.8 Adding Angiotensin Receptor Blockers to ACE Inhibitors 90</p>
<p>6.9 Treating the Underlying Cardiovascular Disease 90</p>
<p>6.10 Medications to Avoid 90</p>
<p>6.11 Prescribing for Heart Failure with Preserved Systolic Function 92</p>
<p>6.12 Prescribing for Multiple Comorbidities 92</p>
<p>6.13 Prescribing at the End of Life 93</p>
<p>References 93</p>
<p>7 Non–Pharmacological Management 97<br />Sinéad P. McKee and Miles D. Witham</p>
<p>7.1 Exercise Training 97</p>
<p>7.2 Types of Exercise Programme 98</p>
<p>7.3 Smoking 100</p>
<p>7.4 Diet 101</p>
<p>7.5 Alcohol 103</p>
<p>7.6 Vaccinations 104</p>
<p>7.7 Psychological Interventions 104</p>
<p>References 104</p>
<p>8 Comorbidity 107<br />Andrew Elder</p>
<p>8.1 Introduction 107</p>
<p>8.2 The Prevalence of Comorbidities 109</p>
<p>8.3 The Implications of Comorbidity 109</p>
<p>8.4 Specific Comorbidities in Heart Failure 111</p>
<p>References 127</p>
<p>9 Treatment and Management in Primary Care 133<br />Alan Begg</p>
<p>9.1 Introduction 134</p>
<p>9.2 The Role of Primary Care and the Patient Population 134</p>
<p>9.3 Heart Failure Registers, Data Collection and Audit 135</p>
<p>9.4 Heart Failure in General Practice 140</p>
<p>9.5 Treatment and Management 146</p>
<p>9.6 Specific Problems in Treating Older Patients 150</p>
<p>References 152</p>
<p>10 The Role of the Specialist Nurse 157<br />Sinéad P. McKee</p>
<p>10.1 Introduction 157</p>
<p>10.2 The Role of the Specialist Nurse 158</p>
<p>10.3 Clinic–Based versus Home–Based Service 163</p>
<p>10.4 Multidisciplinary Team Liaison 165</p>
<p>10.5 Specific Issues Affecting Older Patients 166</p>
<p>10.6 End of Life Care 169</p>
<p>10.7 Specialist Nurses and Education 169</p>
<p>References 171</p>
<p>11 The Role of the Heart Failure Specialist 175<br />Maheshwar Pauriah, Aaron K.F. Wong and Chim C. Lang</p>
<p>11.1 Introduction 175</p>
<p>11.2 The Role of the Heart Failure Specialist 176</p>
<p>11.3 The Provision of a Diagnostic Service and Patient Assessment 177</p>
<p>11.4 Management of Patients with Acute or Worsening Heart Failure Symptoms 178</p>
<p>11.5 Optimization of Heart Failure Treatment 180</p>
<p>11.6 Treatment of Reversible Causes of Heart Failure 184</p>
<p>11.7 Treatment of Concomitant Diseases 187</p>
<p>11.8 Multidisciplinary Care 189</p>
<p>References 191</p>
<p>12 Hospitalization 197<br />Andrew Hannah</p>
<p>12.1 The Epidemiology of Hospitalization 197</p>
<p>12.2 The Aetiology of Heart Failure in Hospitalized Patients 198</p>
<p>12.3 Classification and Diagnosis of Acute Heart Failure (AHF) 199</p>
<p>12.4 Causes and Precipitants of Hospitalization 201</p>
<p>12.5 Treatment of Acute Heart Failure 205</p>
<p>12.6 Management of the Common Cardiac Causes of Hospitalization for Heart Failure 208</p>
<p>12.7 Outcomes in Patients Hospitalized for Heart Failure 209</p>
<p>12.8 Strategies to Reduce Admissions and Readmissions in Patients with Heart Failure 210</p>
<p>References 211</p>
<p>13 Models of Care and Disease Management Programmes 215<br />Martin Wilson and Stephen J. Leslie</p>
<p>13.1 Introduction 215</p>
<p>13.2 Disease Management Programmes 218</p>
<p>13.3 Disease Management Programmes: The Evidence 227</p>
<p>13.4 Guidelines and Critical Care Pathways 228</p>
<p>13.5 Remote and Rural Issues 231</p>
<p>13.6 Telecardiology in Heart Failure 232</p>
<p>13.7 Conclusions 235</p>
<p>References 235</p>
<p>14 Palliative and Supportive Care for Patients with Advanced and Terminal Heart Failure 241<br />Christopher Ward, Francis G. Dunn, Shona M.M. Jenkins and Martin Leiper</p>
<p>14.1 What is Palliative Care? 242</p>
<p>14.2 Age–Related Problems and the Provision of Palliative Care 243</p>
<p>14.3 Advanced and Terminal Heart Failure 244</p>
<p>14.4 Management of Specific Symptoms 248</p>
<p>14.5 Home and Hospital Care 253</p>
<p>14.6 Withdrawal of Conventional Drugs 254</p>
<p>14.7 The Palliative Care Needs of Heart Failure Patients 254</p>
<p>14.8 Palliative Care Strategies for Heart Failure 256</p>
<p>14.9 Timing the Introduction of Different Palliative Care Strategies 256</p>
<p>14.10 Cardiological Issues 259</p>
<p>14.11 The Management Implications of Advanced Heart Failure 260</p>
<p>14.12 Control of Symptoms Using Mostly Generic Treatments 261</p>
<p>14.13 Support in the Community: The Gold Standard Framework (GSF) and Advanced Care Planning (ACP) 262</p>
<p>14.14 Terminal Heart Failure: Identifying the Dying Patient and Providing End–of–Life Care 263</p>
<p>References 265</p>
<p>Index 271</p>